Kessous R, Wissing MD, Piedimonte S, Abitbol J, et al. CA-125 reduction during neoadjuvant chemotherapy is associated with success of cytoreductive surgery and outcome of patients with advanced high-grade ovarian cancer. Acta Obstet Gynecol Scand 2020 Jan 18. doi: 10.1111/aogs.13814.
PMID: 31954071